TELA Bio, Inc. financial data

Symbol
TELA on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
1 Great Valley Parkway, Suite 24, Malvern, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 377 % -24.1%
Quick Ratio 85.2 % -10.2%
Debt-to-equity 589 % +141%
Return On Equity -384 % -90.3%
Return On Assets -55.7 % +4.9%
Operating Margin -49.2 % +34.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 39.6M shares +60.5%
Common Stock, Shares, Outstanding 39.4M shares +60.8%
Entity Public Float 115M USD -53.3%
Common Stock, Value, Issued 39K USD +62.5%
Weighted Average Number of Shares Outstanding, Basic 28.5M shares +24.7%
Weighted Average Number of Shares Outstanding, Diluted 28.5M shares +24.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 69.3M USD +18.6%
Research and Development Expense 8.81M USD -8.38%
Selling and Marketing Expense 64.6M USD +8.32%
General and Administrative Expense 14.7M USD -1.11%
Operating Income (Loss) -34.1M USD +22.6%
Nonoperating Income (Expense) -3.87M USD -49.5%
Net Income (Loss) Attributable to Parent -37.8M USD +18.9%
Earnings Per Share, Basic -1.33 USD/shares +34.8%
Earnings Per Share, Diluted -1.33 USD/shares +34.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 52.7M USD +12.7%
Inventory, Net 12.8M USD -2.9%
Assets, Current 78.1M USD +8.85%
Deferred Income Tax Assets, Net 140K USD
Property, Plant and Equipment, Net 2.34M USD +18%
Operating Lease, Right-of-Use Asset 1.74M USD -11.1%
Intangible Assets, Net (Excluding Goodwill) 1.74M USD -17.9%
Other Assets, Noncurrent 2.28M USD
Assets 86.6M USD +10.9%
Accounts Payable, Current 2.15M USD +28.8%
Employee-related Liabilities, Current 7.34M USD -20.3%
Accrued Liabilities, Current 13.5M USD -12.1%
Liabilities, Current 15.6M USD -8.07%
Operating Lease, Liability, Noncurrent 1.4M USD -17.6%
Other Liabilities, Noncurrent 1.39M USD -17.5%
Liabilities 58.1M USD -1.78%
Accumulated Other Comprehensive Income (Loss), Net of Tax 90K USD -1.1%
Retained Earnings (Accumulated Deficit) -359M USD -11.8%
Stockholders' Equity Attributable to Parent 28.5M USD +50.7%
Liabilities and Equity 86.6M USD +10.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.4M USD -24.3%
Net Cash Provided by (Used in) Financing Activities 56K USD
Net Cash Provided by (Used in) Investing Activities 4.7M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 39.4M shares +60.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.59M USD +19.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 52.9M USD +12.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.18M USD +7.46%
Deferred Tax Assets, Valuation Allowance 76.8M USD +8.01%
Deferred Tax Assets, Gross 77.7M USD +7.88%
Operating Lease, Liability 1.94M USD -14%
Depreciation 139K USD +15.8%
Payments to Acquire Property, Plant, and Equipment 304K USD +164%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -37.8M USD +19%
Lessee, Operating Lease, Liability, to be Paid 3.14M USD -16.1%
Property, Plant and Equipment, Gross 7M USD +10.8%
Operating Lease, Liability, Current 545K USD -3.54%
Lessee, Operating Lease, Liability, to be Paid, Year Two 557K USD -3.97%
Lessee, Operating Lease, Liability, to be Paid, Year One 580K USD -3.49%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.2M USD -19.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 570K USD +2.33%
Deferred Tax Assets, Operating Loss Carryforwards 66.3M USD +7.88%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 583K USD +2.28%
Operating Lease, Payments 400K USD +33.3%
Additional Paid in Capital 387M USD +14%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 896K USD -2.61%
Share-based Payment Arrangement, Expense 4.36M USD -13.3%
Interest Expense 5.31M USD +21%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%